Nemaura Medical to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference
January 07 2022 - 8:00AM
Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company
focused on developing and commercializing non-invasive wearable
diagnostic devices and supporting personalized lifestyle coaching
programs, announces today that CEO Dr. Faz Chowdhury will present a
corporate overview at the H.C. Wainwright Bioconnect 2022 Virtual
Conference, which is taking place on January 10 – 13, 2022.
The presentation will be available on-demand
beginning at 7:00 a.m. ET on Monday, January 10, 2022, to H.C.
Wainwright registered attendees of the conference.
Register for the conference here:
https://hcwevents.com/bioconnect/
About Nemaura Medical, Inc.
Nemaura Medical Inc. is a medical technology
company developing and commercializing non-invasive wearable
diagnostic devices. The company is currently commercializing
sugarBEAT® and proBEAT™. sugarBEAT®, a CE mark approved Class IIb
medical device, is a non-invasive and flexible continuous glucose
monitor (CGM) providing actionable insights derived from real time
glucose measurements and daily glucose trend data, which may help
people with diabetes and pre-diabetes to better manage, reverse,
and prevent the onset of diabetes. Nemaura has submitted a PMA
(Premarket Approval Application) for sugarBEAT® to the U.S. FDA.
proBEAT™ combines non-invasive glucose data processed using
artificial intelligence and a digital healthcare subscription
service and has been launched in the U.S. as a general wellness
product as part of its BEAT®diabetes program.
The Company sits at the intersection of the
global Type 2 diabetes market that is expected to reach nearly $59
billion by 2025, the $50+ billion pre-diabetic market, and the
wearable health-tech sector for weight loss and wellness
applications that is estimated to reach $60 billion by 2023.
For more information, please visit
www.NemauraMedical.com.
Contact:
Jules AbrahamCORE
IR917-885-7378julesa@coreir.com
Nemaura Medical (NASDAQ:NMRD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Nemaura Medical (NASDAQ:NMRD)
Historical Stock Chart
From Jul 2023 to Jul 2024